@article{cdf20f3a098b40c1bb6c0b18673169cb,
title = "Advanced consent for acute stroke trials – Authors' reply",
author = "{van Dijck}, {Jeroen T. J. M.} and Kompanje, {Erwin J. O.} and Nederkoorn, {Paul J.} and Peul, {Wilco C.} and Dippel, {Diederik W. J.}",
note = "Funding Information: DWJD reports that Erasmus MC received research grants from Dutch Heart Foundation, Dutch Brain Foundation, AngioCare BV, Covidien, EV3, Medac, Lamepro, Penumbra, Stryker, Top Medical, Concentric, The Netherlands Organisation for Health Research and Development, Health Holland Top Sector Life Sciences & Health, Stryker European Operations BV, Thrombolytic Science, LLC, and Cerenovus. WCP is part of the management team of the CENTER-TBI study (NCT02210221) and the principal investigator of the Net-QuRe (NL 5761), Ciao@TBI, RESET-ASDH, and the SPARTA trials. All other authors declare no competing interests.",
year = "2021",
month = mar,
day = "1",
doi = "https://doi.org/10.1016/S1474-4422(21)00028-4",
language = "English",
volume = "20",
pages = "170--171",
journal = "Lancet neurology",
issn = "1474-4422",
publisher = "Lancet Publishing Group",
number = "3",
}